Irene Lurkin

2.4k citations

21 papers · 1.6k indexed · h-index 16

Surgery top 5%
Molecular Biology top 10%
Pulmonary and Respiratory Medicine top 10%
Oncology top 10%
Cancer Research top 10%

Co-authors: Ellen C. Zwarthoff Theodorus van der Kwast Bas W.G. van Rhijn Wim J. Kirkels François Radvanyi Madelon N.M. van der Aa Lucie C. Kompier Angela A.G. van Tilborg
Topics: Bladder and Urothelial Cancer Treatments (12 papers)Urinary and Genital Oncology Studies (9 papers)Fibroblast Growth Factor Research (6 papers)
Cited by: Surgery Gastroenterology Cancer Research
Journals: PLoS ONE Cancer Clinical Cancer Research
Partner nations: Netherlands Germany Belgium

In The Last Decade

Irene Lurkin

21 papers receiving 1.5k citations

Peers

Countries citing papers authored by Irene Lurkin

Since Specialization

Citations

This map shows the geographic impact of Irene Lurkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Lurkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Lurkin more than expected).

Fields of papers citing papers by Irene Lurkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Lurkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Lurkin. The network helps show where Irene Lurkin may publish in the future.

Co-authorship network of co-authors of Irene Lurkin

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Lurkin. A scholar is included among the top collaborators of Irene Lurkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Lurkin. Irene Lurkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable 2017 ·PLoS ONE ·Kim E.M. van Kessel,Harmen J.G. van de Werken,Irene Lurkin,(unknown),Ellen C. Zwarthoff,Joost L. Boormans	7
2	20-gene expression signature to predict lymph node positive disease at radical cystectomy for muscle-invasive bladder cancer: Not validated 2017 ·European Urology Supplements ·(unknown),(unknown),Irene Lurkin,(unknown),Ellen C. Zwarthoff,Joost L. Boormans	1
3	Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up 2016 ·Oncotarget ·Rossana Critelli,Francesca Fasanelli,Marco Oderda,Silvia Polidoro,M Assumma,Clara Viberti,Mirko Preto,Paolo Gontero,(unknown),Irene Lurkin,Ellen C. Zwarthoff,Paolo Vineis,Carlotta Sacerdote,Giuseppe Matullo,Alessio Naccarati	51
4	Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy 2016 ·The Journal of Urology ·Kim E.M. van Kessel,Willemien Beukers,Irene Lurkin,(unknown),Kirstin A. van der Keur,Joost L. Boormans,Lars Dyrskjøt,Mirari Márquez,Torben F. Ørntoft,Francisco X. Real,Ulrika Segersten,Núria Malats,Per‐Uno Malmström,Wim Van Criekinge,Ellen C. Zwarthoff	107
5	Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium 2015 ·Gynecologic Oncology ·Yvette P. Geels,Louis J.M. van der Putten,Angela A.G. van Tilborg,Irene Lurkin,Ellen C. Zwarthoff,Johanna M.A. Pijnenborg,(unknown),Marc P.L.M. Snijders,Johan Bulten,Daniel W. Visscher,Sean C. Dowdy,Leon F.A.G. Massuger	14
6	Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria 2015 ·The Journal of Urology ·Kim E.M. van Kessel,Leander Van Neste,Irene Lurkin,Ellen C. Zwarthoff,Wim Van Criekinge	77
7	Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen 2013 ·Breast Cancer Research and Treatment ·(unknown),Jean Helmijr,Maxime P. Look,Irene Lurkin,Kirsten Ruigrok-Ritstier,Steven Van Laere,Luc Dirix,Fred C.G.J. Sweep,Paul N. Span,Sabine C. Linn,John A. Foekens,Stefan Sleijfer,Els M.J.J. Berns,Maurice P.H.M. Jansen	43
8	Keratinocytic epidermal nevi are associated with mosaic RAS mutations 2012 ·Journal of Medical Genetics ·Christian Hafner,Agustí Toll,(unknown),Andreas Mauerer,Irene Lurkin,Francesco Acquadro,(unknown),Ellen C. Zwarthoff,Wolfgang Dietmaier,Eulàlia Baselga,(unknown),Asunción Vicente,(unknown),Juan C. Cigudosa,Thomas Mentzel,Ramón M. Pujol,Michael Landthaler,Francisco X. Real	55
9	KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics 2012 ·Journal of Molecular Diagnostics ·Daniëlle A.M. Heideman,Irene Lurkin,Marije Doeleman,Egbert F. Smit,Henk M.W. Verheul,Gerrit A. Meijer,Peter J.F. Snijders,Erik Thunnissen,Ellen C. Zwarthoff	46
10	Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood 2012 ·PLoS ONE ·Angela A.G. van Tilborg,Lucie C. Kompier,Irene Lurkin,(unknown),Samira El Bouazzaoui,(unknown),Tahlita C.M. Zuiverloon,Lars Dyrskjøt,Torben F. Ørntoft,Monique J. Roobol,Ellen C. Zwarthoff	15
11	Absence of BRAF and HRAS mutations in eruptive Spitz naevi 2011 ·British Journal of Dermatology ·(unknown),Thomas Wiesner,Lorenzo Cerroni,Irene Lurkin,Ellen C. Zwarthoff,M. Landthaler,Christian Hafner	10
12	Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST) 2011 ·Cancer Letters ·(unknown),Irene Lurkin,(unknown),E Erbstösser,(unknown),(unknown),(unknown),(unknown),Gabriele Krüger,J. Knolle,(unknown),Friedrich Prall,(unknown),H. Lobeck,(unknown),F Theissig,Peter H. Wünsch,Ellen C. Zwarthoff,Abbas Agaimy,Regine Schneider‐Stock	111
13	FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy 2010 ·PLoS ONE ·Lucie C. Kompier,Irene Lurkin,Madelon N.M. van der Aa,Bas W.G. van Rhijn,Theodorus van der Kwast,Ellen C. Zwarthoff	242
14	Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes 2010 ·PLoS ONE ·Irene Lurkin,Robert Stoehr,Carolyn D. Hurst,Angela A.G. van Tilborg,Margaret A. Knowles,Arndt Hartmann,Ellen C. Zwarthoff	79
15	The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour 2008 ·The Journal of Pathology ·Lucie C. Kompier,(unknown),Irene Lurkin,Marcel Vermeij,Wim J. Kirkels,Chris H. Bangma,Theodorus van der Kwast,Ellen C. Zwarthoff	39
16	Lack of genetic and epigenetic changes in meningiomas without NF2 loss 2005 ·The Journal of Pathology ·(unknown),Bruno Morolli,(unknown),A. de Vries,(unknown),Irene Lurkin,Johan M. Kros,Ellen C. Zwarthoff	21
17	A Simple and Fast Method for the Simultaneous Detection of Nine Fibroblast Growth Factor Receptor 3 Mutations in Bladder Cancer and Voided Urine 2005 ·Clinical Cancer Research ·Johanna M.M. van Oers,Irene Lurkin,(unknown),(unknown),Bas W.G. van Rhijn,Madelon N.M. van der Aa,Ellen C. Zwarthoff	128
18	Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine. 2003 ·PubMed ·Bas W.G. van Rhijn,Irene Lurkin,Dominique Chopin,Wim J. Kirkels,Jean Paul Thiery,Theodorus van der Kwast,François Radvanyi,Ellen C. Zwarthoff	65
19	Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders 2002 ·European Journal of Human Genetics ·Bas W.G. van Rhijn,Angela A.G. van Tilborg,Irene Lurkin,Jacky Bonaventure,A. de Vries,Jean Paul Thiery,Theodorus van der Kwast,Ellen C. Zwarthoff,François Radvanyi	126
20	Microsatellite analysis?DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma 2001 ·Cancer ·Bas W.G. van Rhijn,Irene Lurkin,Wim J. Kirkels,Theodorus van der Kwast,Ellen C. Zwarthoff	74

About Irene Lurkin

Irene Lurkin is a scholar working on Urology, Surgery and Cancer Research, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (9 papers) and Fibroblast Growth Factor Research (6 papers). The work is most often cited by research in Surgery (904 citations), Gastroenterology (102 citations) and Cancer Research (238 citations). Irene Lurkin has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include Ellen C. Zwarthoff, Theodorus van der Kwast, Bas W.G. van Rhijn, Wim J. Kirkels, François Radvanyi, Madelon N.M. van der Aa, Lucie C. Kompier, Bas W.G. van Rhijn, Angela A.G. van Tilborg and Kim E.M. van Kessel. Their work appears in journals such as PLoS ONE, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact